The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease
Abstract
Objective We evaluated microRNAs (miRNAs) as potential biomarkers for Alzheimer disease (AD) by analyzing the expression level of miRNAs in CSF of patients with AD dementia and nonaffected control subjects. Methods Using quantitative PCR, we profiled the expression level of 728 miRNAs in CSF of nonaffected control subjects and patients with clinically ascertained AD dementia, and we further compared the expression level of candidate miRNAs in 37 control subjects and 35 patients with AD dementia. Results The level of hsa-miR-27a-3p in CSF is reduced in patients with dementia due to AD in 2 different cohorts of subjects (cohort 1: p = 0.008; cohort 2: p = 0.015; 2-tailed unpaired Welch t test). Moreover, low levels of hsa-miR-27a-3p were accompanied by high CSF tau levels and low CSF β-amyloid levels. Conclusions Our pilot study highlights hsa-miR-27a-3p as a candidate biomarker for AD and provides the groundwork for further confirmation studies in larger cohorts and in other hospitals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been reported that more miRNAs can be detected in postmortem CSF, because CSF can be contaminated by miRNAs released from degenerated brain tissues19,37.”
From Intra- and Inter-individual Variability of microRNA Levels in Human Cerebrospinal Fluid: Critical Implications for Biomarker Discovery (2017) · cites this paper as [19]
In the citing paper
“We detected a relatively smaller number of miRNAs in CSF, compared to other miRNA profiling studies19,28.”
From Intra- and Inter-individual Variability of microRNA Levels in Human Cerebrospinal Fluid: Critical Implications for Biomarker Discovery (2017) · cites this paper as [19]
Citations
Cites
Andersen, C. L., Jensen, J. L., & Ørntoft, T. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0496 · Cited by 7,127
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863
Self-citationCogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14103 · Cited by 943
Baraniskin, A., Kuhnhenn, J., Schlegel, U. S., Chan, A., Deckert, M., Gold, R., Maghnouj, A., Zöllner, H., Reinacher‐Schick, A., Schmiegel, W., et al. (2011) · Blood · doi:10.1182/blood-2010-09-308684 · Cited by 303
Bossers, K., Wirz, K. T. S., Meerhoff, G. F., Essing, A. H. W., van Dongen, J. W., Houba, P., Kruse, C. G., Verhaagen, J., & Swaab, D. F. (2010) · Brain · doi:10.1093/brain/awq258 · Cited by 230
Self-citationBjerke, M., Zetterberg, H., Edman, Å., Blennow, K., Wallin, A., & Andreasson, U. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110566 · Cited by 180
Self-citationmiRNA Expression Profiling: From Reference Genes to Global Mean Normalization
D′haene, B., Mestdagh, P., Hellemans, J., & Vandesompele, J. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-427-8_18 · Cited by 175
Regulated microRNAs in the CSF of patients with multiple sclerosis
Haghikia, A., Haghikia, A., Hellwig, K., Baraniskin, A., Holzmann, A., Décard, B. F., Thum, T., & Gold, R. (2012) · Neurology · doi:10.1212/wnl.0b013e3182759621 · Cited by 160
Dysregulated microRNAs in neurodegenerative disorders
Lau, P., & Strooper, B. D. (2010) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2010.01.009 · Cited by 93
Self-citationStudying micro RNA Function and Dysfunction in Alzheimer’s Disease
Lukiw, W. J., Андреева, Т. В., Grigorenko, A. P., & Rogaev, E. I. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2012.00327 · Cited by 76
Cited by
Sorted by citations
Items 101–156 of 156
Yang, J., Zhang, R., Lin, J., Cao, M.-C., Wang, Q., Cui, H., Sun, S.-G., & Wang, L. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000494478 · Cited by 21
Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training
Sousa, R. A. L. D., & Caria, A. C. I. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00903-y · Cited by 19
Bisht, I., Ambasta, R. K., & Kumar, P. (2020) · Neuropeptides · doi:10.1016/j.npep.2020.102078 · Cited by 20
A Comprehensive Review on the Importance of MiRNA-206 in the Animal Model and Human Diseases
Wang, Q., & Guan, W. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230407124146 · Cited by 19
Kondo, M., Yamada, H., Munetsuna, E., Yamazaki, M., Hatta, T., Iwahara, A., Ohashi, K., Ishikawa, H., Tsuboi, Y., Inoue, T., et al. (2019) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2019.01.007 · Cited by 19
Tsamis, K. I., Sakkas, H., Giannakis, A., Ryu, H. S., Gartzonika, C., & Nikas, I. P. (2021) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-021-00513-x · Cited by 17
MicroRNAs mediate the anti-tumor and protective effects of ginsenosides
Ashrafizadeh, M., Ahmadi, Z., Mohammadinejad, R., Farkhondeh, T., & Samarghandian, S. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2019.1675722 · Cited by 18
Expanding the Repertoire of Biomarkers for Alzheimer’s Disease: Targeted and Non-targeted Approaches
Galasko, D. R. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00256 · Cited by 19
Luo, T., Yi, X., & Si, W. (2017) · Oncology Letters · doi:10.3892/ol.2017.6845 · Cited by 17
Mengel‐From, J., Feddersen, S., Halekoh, U., Heegaard, N. H. H., McGue, M. K., Christensen, K., Tan, Q., & Christiansen, L. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0157-8 · Cited by 17
Decrease in Plasma miR-27a and miR-221 After Concussion in Australian Football Players
Shultz, S. R., Taylor, C. J., Aggio‐Bruce, R., O’Brien, W. T., Sun, M., Cioanca, A. V., Neocleous, G., Symons, G. F., Brady, R. D., Hardikar, A. A., et al. (2022) · Biomarker Insights · doi:10.1177/11772719221081318 · Cited by 16
Regulation of P-glycoprotein by miR-27a-3p at the Brain Endothelial Barrier
Hammad, S., Mabondzo, A. M., Hamoudi, R., & Harati, R. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.10.021 · Cited by 15
Devoto, C., Guedes, V. A., Lai, C., Leete, J. J., Mithani, S., Edwards, K. A., Vorn, R., Qu, B., Wilde, E. A., Walker, W. C., et al. (2022) · Brain Injury · doi:10.1080/02699052.2022.2042854 · Cited by 13
Wang, H. (2023) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2023.19 · Cited by 14
Role of viruses, prions and miRNA in neurodegenerative disorders and dementia
Sohrab, S. S., Suhail, M., Ali, A., Kamal, M. A., Husen, A., Ahmad, F., Azhar, E. I., & Greig, N. H. (2018) · VirusDisease · doi:10.1007/s13337-018-0492-y · Cited by 12
Vastrad, B. M., & Vastrad, C. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.06.442918 · Cited by 11
Zhang, H., & Feng, T. (2022) · Biochemical Genetics · doi:10.1007/s10528-022-10280-x · Cited by 11
Novel CSF Biomarkers Tracking Autoimmune Inflammatory and Neurodegenerative Aspects of CNS Diseases
Kapaki, E. N., Vakrakou, A. G., & Boufidou, F. (2022) · Diagnostics · doi:10.3390/diagnostics13010073 · Cited by 11
Sokouti, B. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108860 · Cited by 8
Biomarkers for Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00007-0 · Cited by 9
Li, S., Xiao, J., Yu, Z., Li, J., Shang, H., & Zhang, L. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14470 · Cited by 6
The Influence of Extracellular RNA on Cell Behavior in Health, Disease, and Regeneration
Huleihel, L., Scarritt, M. E., & Badylak, S. F. (2017) · Current Pathobiology Reports · doi:10.1007/s40139-017-0121-2 · Cited by 7
Hashemi, M., Asheghabadi, P. S., Moassesfar, M., Mashhadikhan, S., Nasirzade, S., Farahani, A. V., Mehdizadeh, S., Minaei, S., Rahmani, M., Jamshidian, F., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-025-05510-3 · Cited by 7
Gascón, E., Calvo, A. C., Molina, N., Zaragoza, P., & Osta, R. (2024) · Biomolecules · doi:10.3390/biom14121641 · Cited by 6
Pereira, J. D., Teixeira, L. C. R., Mamede, I., Alves, M. T., Caramelli, P., Luizon, M. R., Veloso, A., & Gomes, K. B. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16060 · Cited by 6
Implication of microRNAs in Alzheimer's disease pathogenesis
Zoltowska, K. M., Laskowska-Kaszub, K., Nagaraj, S., & Wojda, U. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00009-8 · Cited by 6
Sex-associated microRNAs potentially implicated in sporadic Alzheimer’s disease (sAD)
Tsamou, M., & Roggen, E. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148791 · Cited by 5
Abyadeh, M., Yadav, V. K., & Kaya, A. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230684 · Cited by 4
Li, K., Wang, Z., Zhang, J., & Lv, P. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.94490 · Cited by 5
Dovrolis, N., Nikou, M., Gkrouzoudi, A., Dimitriadis, N., & Maroulakou, I. G. (2022) · Biomolecules · doi:10.3390/biom12020263 · Cited by 4
Alzheim(i)R: MicroRNAs in Alzheimer’s Disease
Barbato, C. (2014) · Journal of Cytology & Histology · doi:10.4172/2157-7099.1000e113 · Cited by 3
Omics-driven strategies for identifying biomarkers in Alzheimer’s disease
Khan, Y., Rekha, A., Ballal, S., Maharana, L., Maqbool, M., Goyal, K., Mishra, R., Uniyal, P., Alam, P., Aljarba, T. M., et al. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01873-1 · Cited by 3
Theron, D., Hopkins, L. N., Sutherland, H. G. E., Griffiths, L. R., & Fernandez, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713480 · Cited by 4
miRNAs as biofluid markers for diagnostics of Alzheimer’s disease: recent status and perspectives
Kosikova, N., Cente, M., Cigánková, V., Koson, P., & Filipčík, P. (2018) · General Physiology and Biophysics · doi:10.4149/gpb_2018019 · Cited by 3
Mapping of Nervous System Diseases via MicroRNAs
(2016) · CRC Press eBooks · doi:10.1201/b19229 · Cited by 3
Genetic and Epigenetic Architecture of Alzheimer’s Dementia
Cervera‐Carles, L., & Clarimón, J. (2016) · Current Genetic Medicine Reports · doi:10.1007/s40142-016-0086-1 · Cited by 3
Neurochemical Aspects of Alzheimer Disease
Farooqui, A. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-15889-1_1 · Cited by 2
Chen, X., Hu, F., Chi, Q., & Rao, C. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241295316 · Cited by 2
Genome plasticity and neuropsychiatric disorders
Forero, D. A., Trujillo‐Güiza, M. L., & López‐León, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817819-5.00012-7 · Cited by 2
Genome-Wide Epigenetic Studies in Neurologic Diseases
Woodhoo, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800140-0.00010-8 · Cited by 2
Vastrad, B. M., & Vastrad, C. M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.29.489994 · Cited by 2
Methods for Biomarker Analysis
Franciotta, D. M., Alessio, M., Garzetti, L., & Furlan, R. (2015) · Springer eBooks · doi:10.1007/978-3-319-01225-4_13 · Cited by 1
He, L., Zhang, C., & Wang, J. (2024) · PubMed Central · doi:10.19723/j.issn.1671-167x.2024.02.002 · Cited by 1
Shyam, M., Veronica, A., Wadhwa, J., Sharma, V., Bm, O., Srirangan, P., Venkatesh, R., & Prince, S. E. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12021-4 · Cited by 3
The role of ncRNAs in depression
Luan, X., Xing, H., Guo, F., Liu, W., Jiao, Y., Liu, Z., Wang, X., & Gao, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27307 · Cited by 1
MicroRNAs Regulating Autophagy in Neurodegeneration
Lai, Q., Kovzel, N., Konovalov, R., & Vinnikov, I. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-2830-6_11 · Cited by 1
Feng, H., He, L., chen, Z., & Wang, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1476596/v1 · Cited by 1
New Frontiers in Alzheimer's Disease Diagnosis
Llorens, F., Nuhn, S., Peter, C., Zerr, I., & Stoeck, K. (2015) · InTech eBooks · doi:10.5772/59652 · Cited by 1
17 Neurodegenerative Disorders
Grasso, M., Piscopo, P., Confaloni, A., & Denti, M. A. (2011) · Thieme eBooks · doi:10.1055/b-0034-75424
Potential of Blood- and CSF-Based Biomarkers for Alzheimer’s Disease Diagnostics
Goldwaser, E. L., & Nagele, R. G. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780190634230.003.0016
Decoding the Epigenome of Neuronal Networks in Health and Disease
Jain, G. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7477
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4801-1
Vastrad, B. M., & Vastrad, C. M. (2025) · Genome Instability & Disease · doi:10.1007/s42764-025-00147-x
Vastrad, B. M., Pattanashetti, S., & Vastrad, C. M. (2025) · Advances in Biomarker Sciences and Technology · doi:10.1016/j.abst.2025.08.004
Sarkar, S., Pandey, A. K., Khan, B., & Pant, A. B. (2025) · BMC Genomics · doi:10.1186/s12864-025-11970-7
Metadata
- Authors
- Sala Frigerio, C., Lau, P., Salta, E., Tournoy, J., Bossers, K., Vandenberghe, R., Wallin, A., Bjerke, M., Zetterberg, H., Blennow, K., & De Strooper, B.
- Affiliations
- From the VIB Center for the Biology of Disease (C.S.F., P.L., E.S., B.D.S.), Leuven; Center for Human Genetics and LIND (C.S.F., P.L., E.S., B.D.S.), and Alzheimer Research Centre KU Leuven, Leuven Institute for Neuroscience and Disease (R.V.), University of Leuven; Geriatric Medicine (J.T.), and Neurology Department (R.V.), University Hospitals Leuven; Department of Clinical and Experimental Medicine and LIND (J.T.), Laboratory for Cognitive Neurology, Department of Neurosciences (R.V.), KU Leuven,...
- Netherlands Institute for Neuroscience (NL)
- ORCID
- Venue
- Neurology
- Published
- 2013-12-10
- Volume
- 81
- Issue
- 24
- Pages
- 2103-2106
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W1975366875
- Cited by
- 156
- References
- 10
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 10 · 2023: 10 · 2022: 18 · 2021: 17 · 2020: 9 · 2019: 13 · 2018: 14 · 2017: 15 · 2016: 17 · 2015: 17 · 2014: 9
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, microRNA, cerebrospinal fluid, biomarkers, CSF tau
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Female, Gene Expression Regulation, Humans, Male, Middle Aged, Pilot Projects, Cohort Studies, Biomarkers, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
